Literature DB >> 2439839

Dynamic and kinetic differences of the vascular and myocardial effects of calcium antagonists in the rat heart.

F T van Amsterdam, M Haas, J Zaagsma.   

Abstract

We studied the effects of nifedipine, nimodipine, verapamil, D600 (gallopamil), D888 (desmethoxyverapamil), D890 (quaternized verapamil), bepridil, and diltiazem on the coronary flow and the left ventricular pressure in the retrogradely perfused paced rat heart; in addition, we investigated the time course of onset and recovery of these effects. We found a clear difference in potency order for the vascular and cardiac effects as well as widely different kinetics of coronary flow increase and negative inotropic activity. Furthermore, positive inotropism at low doses of some calcium antagonists seemed to be related to the vascular effects of these compounds. We conclude that the rat heart contains a hydrophylic and readily accessible, vascular "dihydropyridine" site and a more hydrophobic, possibly intramembraneous or intracellular, myocardial "verapamil" site with a lower accessibility for verapamil derivatives and bepridil.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439839     DOI: 10.1097/00005344-198705000-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations.

Authors:  J G Hugtenburg; M J Mathy; H W Boddeke; J J Beckeringh; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

2.  Positive inotropic effects of calcium channel antagonists are not necessarily caused by partial calcium channel agonism.

Authors:  N C Punt; F T van Amsterdam; M M Goddijn; M Haas; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

3.  Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.

Authors:  P A Calle; M G Bogaert; L De Ridder; W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Stereoisomers of BAY K 8644 show opposite activities in the normal and ischaemic rat heart. A comparison with nifedipine.

Authors:  F T van Amsterdam; N C Punt; M Haas; M S van Amsterdam-Magnoni; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

5.  The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.

Authors:  J G Hugtenburg; M J Mathy; J J Beckeringh; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

6.  Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.

Authors:  F T van Amsterdam; M S van Amsterdam-Magnoni; M Haas; N C Punt; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

7.  Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.

Authors:  Y Nasa; K Ichihara; R Yoshida; Y Abiko
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

8.  Differential inhibition of neuronal calcium entry and [3H]-D-aspartate release by the quaternary derivatives of verapamil and emopamil.

Authors:  R A Keith; T J Mangano; P A DeFeo; G E Ernst; E J Warawa
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Effect of changes in aortic pressure and in coronary arterial pressure on left ventricular geometry and function Anrep vs. gardenhose effect.

Authors:  J D Schipke; I Stocks; U Sunderdiek; G Arnold
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

10.  Stereoisomers of calcium antagonists discriminate between coronary vascular and myocardial sites.

Authors:  F T van Amsterdam; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.